Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,140 | -13,290 | -12,910 | -3,328 | -1,841 |
| Depreciation Amortization | 1,138 | 68 | 80 | 59 | 31 |
| Accounts receivable | -396 | -85 | -16 | -21 | -21 |
| Accounts payable and accrued liabilities | 386 | 301 | 189 | 138 | 114 |
| Other Working Capital | 640 | 306 | 450 | 7 | 134 |
| Other Operating Activity | 17,723 | 10,248 | 7,248 | 61 | 20 |
| Operating Cash Flow | $-5,649 | $-2,452 | $-4,960 | $-3,082 | $-1,563 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66 | -32 | -20 | -29 | -26 |
| Purchase Sale Intangibles | -49 | -12 | -9 | N/A | N/A |
| Other Investing Activity | -49 | -12 | -10 | -10 | -261 |
| Investing Cash Flow | $-116 | $-45 | $-30 | $-39 | $-287 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,900 | 2,400 | 3,284 | 2,148 | 800 |
| Debt Repayment | -51 | N/A | -200 | -3 | -3 |
| Common Stock Issued | 166 | 166 | 1,724 | 707 | 707 |
| Other Financing Activity | -50 | -1 | -109 | 0 | 0 |
| Financing Cash Flow | $6,966 | $2,565 | $4,700 | $2,852 | $1,505 |
| Beginning Cash Position | 126 | 126 | 420 | 423 | 423 |
| End Cash Position | 1,327 | 195 | 120 | 154 | 78 |
| Net Cash Flow | $1,201 | $69 | $-290 | $-269 | $-345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,649 | -2,452 | -4,960 | -3,082 | -1,563 |
| Capital Expenditure | -66 | -32 | -29 | -29 | -26 |
| Free Cash Flow | -5,716 | -2,484 | -4,989 | -3,111 | -1,589 |